Table 5 Logistic regression analysis of clinical diagnosis (INCPH versus non-INCPH control groups) against histologic features.
Histologic feature | INCPH vs Non-INCPH control 1 | INCPH vs Non-INCPH control 2 | ||
|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |
Portal vein sclerosis | OR = 8.13, 95% CI: 3.15, 20.95, p < 0.001 | OR = 12.89; 95% CI: 2.42, 68.59, p = 0.003 | OR = 13.65, 95% CI: 4.77, 39.03, p < 0.001 | OR = 19.18; 95% CI: 3.38, 108.97, p = 0.001 |
Aberrant portal/periportal vessels | OR = 0.95, 95% CI: 0.42, 2.15, p = 0.897 | OR = 0.62; 95% CI: 0.23, 1.69, p = 0.351 | OR = 0.96, 95% CI: 0.41, 2.29, p = 0.934 | OR = 0.43; 95% CI: 0.12, 1.46, p = 0.176 |
Increase in portal fibrous tissue | OR = 3.93, 95% CI: 1.60, 9.64, p = 0.003 | OR = 0.59; 95% CI: 0.11, 3.10, p = 0.536 | OR = 5.72, 95% CI: 2.20, 14.89, p < 0.001 | OR = 0.87; 95% CI: 0.16, 4.63, p = 0.874 |
Nodular regenerative hyperplasia | OR = 1a | OR = 1a | OR = 1a | OR = 1a |